Clinical treatment of bladder cancer: An addition to Affibody-mediated tumor targeting

Reference number
Coordinator Haldex Holding AB - Haldex Holding AB
Funding from Vinnova SEK 542 000
Project duration September 2006 - December 2007
Status Completed

Last updated 25 November 2019

Reference number 2006-01797

Page statistics